Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + Hydroxyurea in Temozolomide-resistant Glioblastoma
NCT00154375Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Aug 2008
- Countries
- 1
01
Overview
A Phase 3 trial of imatinib in glioblastoma multiforme (GBM), astrocytoma, sponsored by Novartis. Started Oct 2004; status: completed.
02
Drugs
03
Conditions
glioblastoma multiforme (GBM)astrocytoma
Beyond the preview
Go deeper on NCT00154375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154375.